Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:1006-1012
Published online before print October 23, 2003, doi: 10.1161/01.RES.0000102957.84247.8F
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/10/1006    most recent
01.RES.0000102957.84247.8Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho Hong, S.
Right arrow Articles by Miller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho Hong, S.
Right arrow Articles by Miller, M.
Related Collections
Right arrow Other Research
(Circulation Research. 2003;93:1006.)
© 2003 American Heart Association, Inc.


Clinical Research

Novel Polypyrimidine Variation (IVS46: del T -39...-46) in ABCA1 Causes Exon Skipping and Contributes to HDL Cholesterol Deficiency in a Family With Premature Coronary Disease

Seung Ho Hong, Jeffrey Rhyne, Michael Miller

From the Department of Medicine, University of Maryland and Veterans Administration Medical Center, Baltimore, Md.

Correspondence to Michael Miller, MD, Division of Cardiology, Room S3B06, University of Maryland Hospital, 22 S Greene St, Baltimore, MD 21201. E-mail mmiller{at}heart.umaryland.edu

Recent studies have implicated mutations in the ATP-binding cassette transporter A1, ABCA1, as a cause of Tangier disease (TD) and familial hypoalphalipoproteinemia (FHA). We investigated a proband with very low levels of high-density lipoprotein cholesterol (HDL-C, 6 mg/dL) and a history of premature coronary heart disease (CHD). Sequencing of the ABCA1 gene revealed 2 distinct variants. The first mutation was a G5947A substitution (R1851Q). The second mutation was a single-nucleotide deletion of thymidine in a polypyrimidine tract located 33 to 46 bps upstream to the start of exon 47. This mutation does not involve the 3' acceptor splice site and is outside the lariat branchpoint sequence (IVS46: del T -39...-46). Amplification of cDNA obtained in cultured fibroblasts of the proband and affected family member revealed an abnormally spliced cDNA sequence with skipping of exon 47. These variants were not identified in over 400 chromosomes of healthy whites. Compound heterozygotes (n=4) exhibited the lowest HDL-C (11±5 mg/dL) and ApoA-I (35±15 mg/dL) compared with wild-type (n=25) (HDL-C 51±14 mg/dL; ApoA-I 133±21 mg/dL) (P<0.0005) or subjects affected with either R1851Q (n=6) (HDL-C 36±8; ApoA-I 117±19) or IVS46: del T -39...-46 (n=5) (HDL-C 31+9; ApoA-I 115+28 (P<0.01). These data suggest that polypyrimidine tract variation may represent a novel mechanism for altered splicing and exon skipping that is independent of traditional intronic variants as previously identified in acceptor/donor splice regions or the lariat branchpoint domain.


Key Words: ABCA1 • HDL cholesterol deficiency • mutation • polypyrimidine




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Duriez, P. Duquesnoy, E. Escudier, A.-M. Bridoux, D. Escalier, I. Rayet, E. Marcos, A.-M. Vojtek, J.-F. Bercher, and S. Amselem
A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia
PNAS, February 27, 2007; 104(9): 3336 - 3341.
[Abstract] [Full Text] [PDF]